|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The sequence recognition, structure and function of the IMP family of mRNA binding proteins
|
5F30CA214009-02
|
$49,524
|
|
BISWAS, JEETAYU
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-30
|
$396,625
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
20/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048349-26
|
$68,181
|
|
CRANDALL, JILL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Designing Novel Anti-Cancer Therapeutics: Targeting Methionine Metabolism
|
5F30CA210372-02
|
$49,524
|
|
FIRESTONE, ROSS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
PI3K Isoform Dependence in Adult Hematopoiesis and Myeloid Leukemia
|
5R01CA196973-03
|
$415,736
|
|
GRITSMAN, KIRA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer
|
1R01CA222469-01
|
$549,306
|
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific Meetings
|
5R13AT009161-03
|
$5,000
|
|
PRICE, THEODORE
|
AMERICAN PAIN SOCIETY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
$142,182
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-04S1
|
$39,254
|
$12,954
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
$202,270
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-15
|
$307,800
|
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-05
|
$320,588
|
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
|
5R01CA176691-05
|
$341,059
|
|
LOKESHWAR, VINATA
|
AUGUSTA UNIVERSITY
|
|
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
|
5R01CA182467-06
|
$328,888
|
|
CHENG, CHONGHUI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
5R01CA190776-04
|
$546,636
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Breast Cancer Research Training Program
|
1T32CA203690-01A1
|
$194,523
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel LGR4 Oncogenic Signaling in Breast Cancer Progression and Metastasis
|
5R01CA204926-02
|
$362,569
|
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
The ATM/E2F1 Pathway in DNA Damage and Growth Control
|
5R01CA100857-14
|
$356,625
|
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel therapeutics for targeting checkpoint dysfunction in cancer
|
5R01CA203824-02
|
$362,569
|
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
MOLECULAR DISSECTION OF SEIZURE MICROENVIRONMENT IN MALIGNANT GLIOMA
|
1R01CA223388-01
|
$632,130
|
|
NOEBELS, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
|
1R01CA221946-01
|
$488,881
|
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
THE ROLE OF TELOMERASE REGULATORS IN TELOMERE MAINTENANCE AND GENOMIC INSTABILITY
|
5R01CA211653-02
|
$362,569
|
|
SONGYANG, ZHOU
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
5R01CA183984-04
|
$473,915
|
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenomic Biomarkers to Manage Thyroid Nodule Overdiagnosis and Overtreatment
|
1R21CA223367-01
|
$242,633
|
|
HAHN, MARIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
MiRNAs in hepatocellular carcinoma development and treatment
|
5R01CA139158-07
|
$410,875
|
|
HUANG, WENDONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
|
5R01CA213131-02
|
$430,377
|
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeted activation of autoimmune checkpoints in B cell malignancies
|
5R01CA157644-09
|
$410,875
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Androgen Signaling in prostate cancer progression and CRPC development
|
5R01CA070297-20
|
$305,119
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
|
5K08CA201591-02
|
$169,560
|
|
WANG, LEO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention
|
5R01CA164019-06
|
$146,146
|
|
YEE, LISA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Complex Role of HSF1 in Breast Cancer
|
5R01CA176326-05
|
$355,719
|
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of selective Pin1 inhibitors to target a common oncogenic mechanism
|
5R01CA205153-02
|
$654,869
|
|
LU, KUN PING
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-08
|
$457,619
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
APOBEC proteins as drivers of chromosomal translocations in solid cancers
|
1R01CA222598-01
|
$404,888
|
|
CHIARLE, ROBERTO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Regulation of the LIN28/let-7 pathway in cancer
|
5R01CA211328-02
|
$404,888
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
p190 RhoGAP signaling in epithelial oncogenesis
|
5R01CA205158-02
|
$404,888
|
|
HANSEN, STEEN
|
BOSTON CHILDREN'S HOSPITAL
|
|
Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
|
1R01CA222355-01
|
$411,068
|
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor
|
5R01CA211646-02
|
$411,481
|
|
ZETTER, BRUCE
|
BOSTON CHILDREN'S HOSPITAL
|
|
Characterization of Thyroid Nodules by Quantitative Ultrasound
|
5R21CA212744-02
|
$190,102
|
|
LEE, STEPHANIE
|
BOSTON MEDICAL CENTER
|
|
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
|
5R01CA208599-02
|
$603,464
|
|
GODFREY, TONY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Role of Tim-3 in determining T cell immunity
|
5R01CA187975-04
|
$377,666
|
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-04
|
$377,464
|
|
CHIOCCA, E
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
5R01CA080946-18
|
$223,000
|
|
GLADYSHEV, VADIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
How does malignancy subvert platelet and megakaryocytic biology?
|
5R01CA200748-02
|
$550,945
|
|
ITALIANO, JOSEPH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Clinical Evaluation of an Implantable Lab-in-a-patient microdevice that measures in-situ response to therapies in advanced ovarian cancer
|
1R21CA216796-01A1
|
$183,736
|
|
JONAS, OLIVER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant field
|
1R01CA222560-01
|
$374,766
|
|
LI, ZHE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
|
5R01CA203636-02
|
$567,838
|
|
NISHINO, MIZUKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
|
5R01CA207982-02
|
$393,195
|
|
WIDLUND, HANS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Depression Research for this search: $22,467,872
|